Death review process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial - PubMed (original) (raw)
Death review process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
A B Miller et al. Control Clin Trials. 2000 Dec.
Abstract
The procedures that have been adopted in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial are described. These procedures have been designed to ensure unbiased decisions on the underlying cause of death for all confirmed or suspected PLCO cancers. A death review committee with a nonvoting chair and three experienced reviewers as members has been appointed. After an initial pilot study, the procedures have been instituted and are working well.
Similar articles
- Coordination and management of a large multicenter screening trial: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
O'Brien B, Nichaman L, Browne JE, Levin DL, Prorok PC, Gohagan JK; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team. O'Brien B, et al. Control Clin Trials. 2000 Dec;21(6 Suppl):310S-328S. doi: 10.1016/s0197-2456(00)00099-4. Control Clin Trials. 2000. PMID: 11189685 - Update of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Andriole GL. Andriole GL. Recent Results Cancer Res. 2014;202:53-7. doi: 10.1007/978-3-642-45195-9_6. Recent Results Cancer Res. 2014. PMID: 24531777 - Changes in and Impact of the Death Review Process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
Miller AB, Feld R, Fontana R, Gohagan JK, Jatoi I, Lawrence W Jr, Miller A, ProroK PC, Rajput A, Sherman M, Welch G, Wright P, Yurgalevitch S, Albertsen P. Miller AB, et al. Rev Recent Clin Trials. 2015;10(3):206-11. doi: 10.2174/1574887110666150730120752. Rev Recent Clin Trials. 2015. PMID: 26238119 Review. - The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status.
Gohagan JK, Prorok PC, Hayes RB, Kramer BS; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team. Gohagan JK, et al. Control Clin Trials. 2000 Dec;21(6 Suppl):251S-272S. doi: 10.1016/s0197-2456(00)00097-0. Control Clin Trials. 2000. PMID: 11189683 - The PLCO Cancer Screening Trial: Background, Goals, Organization, Operations, Results.
Gohagan JK, Prorok PC, Greenwald P, Kramer BS. Gohagan JK, et al. Rev Recent Clin Trials. 2015;10(3):173-80. doi: 10.2174/1574887110666150730123004. Rev Recent Clin Trials. 2015. PMID: 26238115 Review.
Cited by
- Preliminary effects of risk-adapted PSA screening for prostate cancer after integrating PRS-specific and age-specific variation.
Liu X, Duan H, Liu S, Zhang Y, Ji Y, Zhang Y, Feng Z, Li J, Liu Y, Gao Y, Wang X, Zhang Q, Yang L, Dai H, Lyu Z, Song F, Song F, Huang Y. Liu X, et al. Front Genet. 2024 Aug 1;15:1387588. doi: 10.3389/fgene.2024.1387588. eCollection 2024. Front Genet. 2024. PMID: 39149591 Free PMC article. - Risk-stratified multi-round PSA screening for prostate cancer integrating the screening reference level and subgroup-specific progression indicators.
Liu X, Zhang Y, Duan H, Yang L, Sheng C, Fan Z, Liu Y, Gao Y, Wang X, Zhang Q, Lyu Z, Song F, Song F, Huang Y. Liu X, et al. Eur J Med Res. 2023 Jul 26;28(1):257. doi: 10.1186/s40001-023-01228-x. Eur J Med Res. 2023. PMID: 37496058 Free PMC article. - Obesity and prostate cancer screening, incidence, and mortality in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Hurwitz LM, Dogbe N, Barry KH, Koutros S, Berndt SI. Hurwitz LM, et al. J Natl Cancer Inst. 2023 Dec 6;115(12):1506-1514. doi: 10.1093/jnci/djad113. J Natl Cancer Inst. 2023. PMID: 37382561 Free PMC article. - Mortality Benefit of a Blood-Based Biomarker Panel for Lung Cancer on the Basis of the Prostate, Lung, Colorectal, and Ovarian Cohort.
Irajizad E, Fahrmann JF, Marsh T, Vykoukal J, Dennison JB, Long JP, Do KA, Feng Z, Hanash S, Ostrin EJ. Irajizad E, et al. J Clin Oncol. 2023 Sep 20;41(27):4360-4368. doi: 10.1200/JCO.22.02424. Epub 2023 Jun 28. J Clin Oncol. 2023. PMID: 37379494 Free PMC article. - Clinical and Genomic Characterization of Interval Colorectal Cancer in 3 Prospective Cohorts.
Yang K, Cao Y, Gurjao C, Liu Y, Guo CG, Lo CH, Zong X, Drew D, Geraghty C, Prezioso E, Moore M, Williams C, Riley T, Saul M, Ogino S, Giannakis M, Bass A, Schoen RE, Chan AT. Yang K, et al. Gastroenterology. 2022 Dec;163(6):1522-1530.e5. doi: 10.1053/j.gastro.2022.08.020. Epub 2022 Aug 13. Gastroenterology. 2022. PMID: 35970241 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical